Edgewell (NYSE: EPC) awards director 7,817 restricted stock equivalents

Rhea-AI Filing Summary

Edgewell Personal Care Company director Rakesh Sachdev reported an equity award in the form of derivative securities. On February 5, 2026, he received 7,817 restricted stock equivalents at a price of $0 per unit, all held as a direct ownership position.

According to the filing, these restricted stock equivalents are designed to convert into the same number of shares of Edgewell common stock on the day preceding the next annual meeting of shareholders, unless Sachdev elects to defer conversion until his service on the Board of Directors ends. After this transaction, he beneficially owns 7,817 derivative securities tied to Edgewell common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SACHDEV RAKESH

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Equivalents 2-5-2026	7,817	$0.00	--

Holdings After Transaction: Restricted Stock Equivalents 2-5-2026 — 7,817 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SACHDEV RAKESH

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Equivalents 2-5-2026	$0	02/05/2026		A		7,817		(1)	(1)	Common Stock	7,817	$0	7,817	D

Explanation of Responses:

1. Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

	/s/ LaTanya Langley	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Edgewell Personal Care (EPC) report in this Form 4?

Edgewell Personal Care reported that director Rakesh Sachdev received 7,817 restricted stock equivalents on February 5, 2026. These derivative units were granted at a price of $0 per unit and are tied to future delivery of Edgewell common stock, subject to the plan’s conversion rules.

How many restricted stock equivalents were granted to Edgewell director Rakesh Sachdev?

Rakesh Sachdev was granted 7,817 restricted stock equivalents linked to Edgewell common stock. The filing shows these units were acquired in a single transaction and that he beneficially owns 7,817 derivative securities directly following the reported award, with no purchase price paid per unit.

When do the restricted stock equivalents for Edgewell (EPC) convert into common shares?

The restricted stock equivalents convert into Edgewell common stock on the day preceding the next annual meeting of shareholders. However, the reporting person may instead elect to defer this conversion until their service on Edgewell’s Board of Directors ends, extending the timing of share delivery.

Does Rakesh Sachdev pay anything for the restricted stock equivalents reported by Edgewell?

No cash payment is required for these units; the transaction price per restricted stock equivalent is reported as $0. The award represents equity compensation, granting 7,817 derivative securities that will convert into Edgewell common stock under the stated timing and deferral conditions in the filing footnote.

Is the equity award to Edgewell director Rakesh Sachdev held directly or indirectly?

The Form 4 indicates that the 7,817 restricted stock equivalents are held under direct ownership by Rakesh Sachdev. The ownership form is marked as “D” for direct, and no separate trust, partnership, or other indirect holding structure is identified in the provided disclosure.